Identification of a novel inducible cell-surface ligand of CD5 on activated lymphocytes

Journal of Experimental Medicine

Volumn 184, Issue 3, 1996, Pages 811-819

  Biancone, Luigi ^a,b   Bowen, Michael A ^c   Lim, Alice ^a,b   Aruffo, Alejandro ^c   Andres, Giuseppe ^a,b   Stamenkovic, Ivan ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD5 ANTIGEN; HYBRID PROTEIN;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; FLOW CYTOMETRY; LIGAND BINDING; MEMBRANOUS GLOMERULONEPHRITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SPLEEN CELL; T LYMPHOCYTE ACTIVATION;

EID: 0029787549     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.184.3.811     Document Type: Article

References (35)

1. Resnick, D., A. Pearson, and M. Krieger. 1994. The SRCR superfamily: a family reminiscent of the Ig superfamily. Trends Biochem. Sci. 19:5-8.
2. Casali, P., and A.L. Notkins. 1989. CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire. Immunol. Today. 10:364-368.
3. Ishida, H., R. Hastings, J. Kearney, and M. Howard. 1992. Continuous anti-interleukin 10 antibody administration depletes mice of Ly-1 B cells but not conventional B cells. J. Exp. Med. 175:1213-1220.
4. June, C.H., P.S. Rabinovitch, and J.A. Ledbetter. 1987. CD5 antibodies increase intracellular ionized calcium concentration in T cells. J. Immunol. 138:2782-2792.
5. Ledbetter, J.A., P.J. Martin, C.E. Spooner, D. Wofsky, T.T. Tsu, P.G. Beatty, and P. Gladstone. 1985. Antibodies to Tp67 and Tp44 augment and sustain proliferative responses of activated T cells. J. Immunol. 135:2331-2336.
6. Spertini, F., W. Stohl, N. Ramesh, C. Moody, and R.S. Geha. 1991. Induction of human T cell proliferation by a monoclonal antibody to CD5. J. Immunol. 1991:47-52.
7. Alberola-Ila, J., L. Places, D.A. Cantrell, J. Vives, and F. Lozano. 1992. Intracellular events involved in CD5-induced human T-cell activation and proliferation. J. Immunol. 148: 1287-1293.
8. Stanton, T., T.L. Stevens, J.A. Ledbetter, and D. Wofsy. 1986. Anti-ly-1 antibodies induces interleukin 2 release from T cells. J. Immunol. 136:1734-1737.
9. Davies, A.A., S.C. Ley, and M.J. Crumpton. 1992. CD5 is phosphorylated on tyrosine after stimulation of the T-cell antigen receptor complex. Proc. Natl. Acad. Sci. USA. 89:6368-6372.
10. Raab, M., M. Yamamoto, and C.E. Rudd. 1994. The T-cell antigen CD5 acts as a receptor and substrate for the protein-tyrosine kinase p56lck. Mol. Cell Biol. 14:2862-2870.
11. Tarakhovsky, A., S.B. Kanner, J. Hombach, J.A. Ledbetter, W. Muller, N. Killeen, and K. Rajewsky. 1995. A role for CD5 in TCR-mediated signal transduction and thymocyte selection. Science (Wash. DC). 269:535-537.
12. Sun, D., K. Branum, and Q. Sun. 1992. Prevention of experimental autoimmune encephalomyelitis in Lewis rats by treatment with an anti-rat CD5 antibody (OX19). Cell. Immunol. 145:263-271.
13. Plater-Zyberk, C., P.C. Taylor, M.G. Blaylock, and R.N. Maini. 1994. Anti-CD5 therapy decreases seventy of established disease in collagen type II-induced arthritis in DBA/1 mice. Clin. Exp. Immunol. 98:442-447.
14. Van de Velde, H., I. von Hoegen, W. Luo, J.R. Parnes, and K. Thielemans. 1991. The B-cell surface protein CD72/ Lyb-2 is the ligand for CD5. Nature (Lond.). 351:662-665.
15. Luo, W., H. Van de Velde, I. von Hoegen, J.R. Parnes, and K. Thielemans. 1992. Ly-1 (CD5), a membrane glycoprotein of mouse T lymphocytes and a subset of B cells, is a natural ligand of the B cell surface protein Lyb-2 (CD72). J. Immunol. 148:1630-1634.
16. Snow, E.C., J.J. Mond, and B. Subbarao. 1986. Enhancement by monoclonal anti-Lyb-2 antibody of antigen-specific B lymphocyte expansion stimulated by TNP-ficoll and T-lymphocyte-derived factors. J. Immunol. 137:1793-1796.
17. Kamal, M., A. Katira, and J. Gordon. 1991. Stimulation of B lymphocytes via CD72 (human Lyb-2). Eur. J. Immunol. 21: 1419-1424.
18. Subbarao, B., and D.E. Mosier. 1983. Induction of B lymphocyte proliferation by monoclonal anti-Lyb 2 antibody. J. Immunol. 130:2033-2037.
19. Assmann, K.J.M., M.M. Tangelder, W.P.J. Lange, T.M. Tadema, and R.A.P. Koene. 1983. Membranous glomerulonephritis in the mouse. Kidney Int. 24:303-312.
20. Biancone, L., G. Andres, H. Ahn, C. DeMartino, and I. Stamenkovic. 1995. Inhibition of the CD40-CD40 ligand pathway prevents murine membranous glomerulonephritis. Kidney Int. 48:458-468.
21. Aruffo, A., I. Stamenkovic, I. Melnick, C.B. Underhill, and B. Seed. 1990. CD44 is the principal cell-surface receptor for hyaluronate. Cell. 61:1303-1313.
22. Sy, M.S., Y.J. Guo, and I. Stamenkovic. 1992. Inhibition of tumor growth in vivo with a soluble CD44-immunoglobulin) fusion protein. J. Exp. Med. 176:623-627.
23. Hollenbough, D., L.S. Grosmaire, C.D. Kullas, N.J. Chalupny, S. Braesch-Andersen, R.J. Noelle, I. Stamenkovic, J.A. Ledbetter, and A. Aruffo. 1992. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO (Eur. Mol. Biol. Organ.) J. 11:4313-4321.
24. Sgroi, D., R.N. Cohen, E.G. Lingenheld, M.K. Strong, T. Binder, I. Goldschneider, D. Greiner, M. Grunnet, and R.B. Clark. 1986. T cell lines derived from the spinal cords of mice with experimental allergic encephalomyelitis are self reactive. J. Immunol. 137:1850-1854.
25. + T cell subsets. J. Immunol. 148:4054-4065.
26. Deleted in proof.
27. Kuiper, H.M., M. Brouer, P.S. Linsley, and R.A.W. van Lier. 1995. Activated T cells can induce high levels of CTLA-4 expression on B cells. J. Immunol. 155:1776-1783.
28. Bevilacqua, M.P., and R.M. Nelson. 1993. Selectins. J. Clin. Invest. 91:379-387.
29. Sgroi, D., A. Varki, S. Braesh-Andersen, and I. Stamenkovic. 1993. CD22, a B cell-specific immunoglobulin superfamily member, is a sialic acid-binding lectin. J. Biol. Chem. 268: 7011-7018.
30. Crocker, P.R., S. Mucklow, V. Bouckson, A. McWilliam, A.C. Willis, S. Gordon, G. Milon, S. Kelm, and P. Bradfield. 1994. Sialoadhesin, a macrophage sialic acid binding receptor for haemopoietic cells with 17 immunoglobulin-like domains. EMBO (Eur. Mol. Biol. Organ.) J. 13:4490-4503.
31. Freeman, S.D., S. Kelm, E.K. Barber, and P.R. Crocker. 1995. Characterization of CD33 as a new member of the sialoadhesin family of cellular interaction molecules. Blood. 85: 2005-2012.
32. Aruffo, A., S.B. Kanner, D. Sgroi, J.A. Ledbetter, and I. Stamenkovic. 1992. CD22-mediated stimulation of T cells regulates T-cell receptor/CD3-induced signaling. Proc. Natl. Acad. Sci. USA. 89:10242-10246.
33. Sgroi, D., G.A. Koretzky, and I. Stamenkovic. 1995. Regulation of CD45 engagement by the B-cell receptor CD22. Proc. Acad. Natl. Sci. USA. 92:4026-4039.
34. Wyss, D., J.S. Choi, J. Li, M.H. Knoppers, K.J. Willis, A.R.N. Arulanandam, A. Smolyar, E.L. Reinherz, and G. Wagner. 1995. Conformation and function of the N-linked glycan in the adhesion domain of human CD2. Science (Wash. DC). 269:1273-1278.
35. Sgroi, D., A. Nocks, and I. Stamenkovic. 1996. A single N-linked glycosylation site is implicated in the regulation of ligand recognition by the I-type lectins CD22 and CD33. J. Biol. Chem. 271:18803-18809.